Clinical Trials Browser

Phase 1/2 × Platinum-resistant Ovarian Cancer × 90 days × Clear all

NCT05551507 2026-05-04

IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer

Phase 1/2 Recruiting

Platinum-resistant Ovarian Cancer